Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison.

Preliminary clinical and laboratory observations suggest that nifedipine might prevent progression of threatened myocardial infarction by reversing coronary spasm or might limit necrosis during the course of acute myocardial infarction. We screened 3143 patients with ischemic pain of greater than 45 min duration and randomly assigned 105 eligible patients with threatened myocardial infarction and 66 with acute myocardial infarction to receive nifedipine (20 mg orally every 4 hr for 14 days) or placebo plus standard care. Treatment was started 4.6 +/- 0.1 hr after the onset of pain. Infarct size index was calculated by the MB-creatine kinase (CK) method and expressed as CK-geq/m2 +/- SE. The incidence of progression to infarction among patients with threatened myocardial infarction was not significantly altered by nifedipine (36 of 48 [75%] for placebo-treated and 43 of 57 [75%] for nifedipine-treated patients). Furthermore, infarct size index was similar among placebo- and nifedipine-treated patients (16.9 +/- 1.5 MB-CK-geq/m2, n = 65, and 17.0 +/- 1.5 MB-CK-geq/m2, n = 68, respectively) with threatened myocardial infarction who exhibited infarction and for those with acute myocardial infarction. Among the 171 eligible patients randomly assigned to drug or placebo, 6 month mortality did not differ significantly (8.5% for placebo vs 10.1% for nifedipine, NS), but mortality in the 2 weeks after randomization was significantly higher for nifedipine-treated patients (0% for placebo compared with 7.9% for nifedipine, p = .018).(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  R. Ideker,et al.  Comparison of enzymatic and anatomic estimates of myocardial infarct size in man. , 1984, Circulation.

[2]  G. Vincent,et al.  Coronary spasm producing coronary thrombosis and myocardial infarction. , 1983, The New England journal of medicine.

[3]  P. R. Frederick,et al.  A randomized trial of intracoronary streptokinase in the treatment of acute myocardial infarction. , 1983, The New England journal of medicine.

[4]  W. O’Neill,et al.  Intracoronary fibrinolytic therapy in acute myocardial infarction. Report of a prospective randomized trial. , 1983, The New England journal of medicine.

[5]  L. Opie,et al.  Protective effects on isolated hearts with developing infarction: slow channel blockade by diltiazem versus beta-adrenoceptor antagonism by metoprolol. , 1982, The American journal of cardiology.

[6]  G. Geary,et al.  Quantitative Effect of Early Coronary Artery Reperfusion in Baboons: Extent of Salvage of the Perfusion Bed of an Occluded Artery , 1982, Circulation.

[7]  J. D. Jong,et al.  Acute Hemodynamic Effects of Nifedipine in Patients with Ischemic Heart Disease , 1982, Circulation.

[8]  K. Karsch,et al.  Changes in coronary artery morphology following spasmolytic therapy in acute myocardial infarction , 1982 .

[9]  G. T. Smith,et al.  Failure of nifedipine therapy to reduce myocardial infarct size in the baboon. , 1982, The American journal of cardiology.

[10]  R. Helfant,et al.  The Effects of Nifedipine on Myocardial Blood Flow and Contraction During Ischemia in the Dog , 1982, Circulation.

[11]  R. Chahine,et al.  Interim report of multicenter double-blind, placebo-controlled studies of nifedipine in chronic stable angina. , 1981, The American journal of medicine.

[12]  D. Waters,et al.  Hemodynamic effects of a single oral dose of nifedipine following acute myocardial infarction. , 1980, Chest.

[13]  R. Millard Changes in cardiac mechanics and coronary blood flow of regionally ischemic porcine myocardium induced by diltiazem. , 1980, Chest.

[14]  E. Antman,et al.  Nifedipine therapy for coronary-artery spasm. Experience in 127 patients. , 1980, The New England journal of medicine.

[15]  J. Hansen,et al.  Verapamil in Acute Myocardial Infarction , 1980, Danish medical bulletin.

[16]  J. Williamson,et al.  Effects of Nifedipine on Myocardial Perfusion and Ischemic Injury in Dogs , 1978, British journal of clinical practice. Supplement.

[17]  R. Zelis,et al.  Nifedipine therapy for stable angina pectoris: preliminary results of effects on angina frequency and treadmill exercise response. , 1979, The American journal of cardiology.

[18]  R. E. Clark,et al.  Effect of nifedipine on myocardial ischemia: analysis of collateral flow, pulsatile heat and regional muscle shortening. , 1979, The American journal of cardiology.

[19]  F. Pedersen,et al.  EFFECT OF ALPRENOLOL ON MORTALITY AMONG PATIENTS WITH DEFINITE OR SUSPECTED ACUTE MYOCARDIAL INFARCTION Preliminary Results , 1979, The Lancet.

[20]  W. Ganz,et al.  The Effect of Delay in Propranolol Administration on Reduction of Myocardial Infarct Size After Experimental Coronary Artery Occlusion in Dogs , 1979, Circulation.

[21]  K. Fox,et al.  The Effects of Nifedipine on Acute Experimental Myocardial Ischemia and Infarction in Dogs , 1979, Circulation research.

[22]  S. Chierchia,et al.  Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of "preinfarction" angina. , 1978, The New England journal of medicine.

[23]  S. Vatner,et al.  Effects of coronary artery reperfusion on myocardial infarct size calculated from creatine kinase. , 1978, The Journal of clinical investigation.

[24]  E. Braunwald,et al.  Precordial electrocardiographic mapping. A technique to assess the efficacy of interventions designed to limit infarct size. , 1978, Circulation.

[25]  E. S. Weiss,et al.  Myocardial contracture and accumulation of mitochondrial calcium in ischemic rabbit heart. , 1977, The American journal of physiology.

[26]  J. Lowe,et al.  The Wavefront Phenomenon of Ischemic Cell Death: 1. Myocardial Infarct Size vs Duration of Coronary Occlusion in Dogs , 1977, Circulation.

[27]  R. E. Clark,et al.  Pharmacological preservation of the ischemic heart. , 1977, The Annals of thoracic surgery.

[28]  P. B. Oliva,et al.  Arteriographic Evidence of Coronary Arterial Spasm in Acute Myocardial Infarction , 1977, Circulation.

[29]  J. Lowe,et al.  Effect of the Calcium Antagonist Verapamil on Necrosis following Temporary Coronary Artery Occlusion in Dogs , 1977, Circulation.

[30]  N. Mantel Tests and limits for the common odds ratio of several 2 × 2 contingency tables: methods in analogy with the Mantel-Haenszel procedure , 1977 .

[31]  B. Sobel,et al.  An Improved Basis for Enzymatic Estimation of Infarct Size , 1975, Circulation.

[32]  V. Mathur,et al.  Maximal revascularization (reperfusion) in intact conscious dogs after 2 to 5 hours of coronary occlusion. , 1975, The American journal of cardiology.

[33]  J. D. Morris,et al.  The reversibility of acute ischemic injury to the myocardium by restoration of coronary flow. , 1972, The Journal of thoracic and cardiovascular surgery.

[34]  T. Killip,et al.  Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. , 1967, The American journal of cardiology.

[35]  W. J. Langford Statistical Methods , 1959, Nature.